Hot Deals:
a v thomas 15,555.00 (3.70 %) adtech 29.10 (0.34 %) agarwal bolts 1,200.00 (-0.83 %) amol minechem 520.00 (-16.13 %) anand i-power 20.00 anglo french 350.00 (-5.41 %) apl metals 42.01 (0.02 %) arkfin investments 50.00 arohan 115.00 (-2.54 %) assam carbon 195.00 (-4.88 %) atlas copco 10,000.00 (1.01 %) auckland international 129.00 (-0.77 %) axles 190.00 (2.70 %) balmer lawrie 199.00 (1.02 %) bharat hotels 144.00 (-0.69 %) bima mandi 700.00 bira 650.00 (3.83 %) boat 715.00 (-1.38 %) c & s electric 545.00 (7.92 %) cable corporation 15.00 capgemini 10,700.00 (1.86 %) care health 154.00 (1.99 %) carrier aircon 276.00 (0.36 %) cial 163.00 (1.24 %) csfbl 365.00 (-3.44 %) csk 160.00 (-1.84 %) dalmia refract 130.00 (4.00 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 49.00 (2.08 %) eaton fluid 440.00 (-2.22 %) electronica plastic 4,100.00 (-0.24 %) elgi ultra 400.00 elofic 2,050.00 (4.06 %) esl steel 32.00 (-3.03 %) fincare business 43.00 fincare sfbl 191.00 (0.53 %) finopaytech 115.00 (-3.36 %) flipkart india 231,001.00 (0.00 %) frick india 3,800.00 (2.70 %) gkn drive 1,090.00 (-0.91 %) go digit general insurance ltd 354.00 (1.14 %) godavari bio 71.00 (1.43 %) hdb financial 640.00 (-0.78 %) hdfc ergo 370.00 (1.70 %) hdfc securities 10,500.00 (1.94 %) hella india 575.00 (4.55 %) hero fincorp 1,050.00 (1.94 %) hexaware 530.00 (1.92 %) hicks 1,700.00 (-0.58 %) hira ferro 130.00 (8.33 %) honeywell electrical 3,333.00 (-1.97 %) icex 0.10 (-0.10 %) ikf finance 214.00 (4.90 %) incred financial 100.00 india carbon 945.00 (-0.53 %) india exposition 144.00 (-1.37 %) indian potash 1,390.00 (-0.71 %) indofil 650.00 (-2.99 %) infinite computer 405.00 (1.25 %) inkel 12.00 (-1.64 %) ixigo 87.00 (-1.14 %) jana sfbl 75.00 kel 550.00 (3.77 %) kial 104.00 (-0.95 %) klm axiva 17.50 (-1.13 %) kurlon limited 310.00 (1.31 %) lava 96.00 (-1.03 %) manipal housing 72.50 (0.69 %) manjushree tech 930.00 (3.33 %) martin & harris 1,070.00 (-0.93 %) merino 2,530.00 (-0.78 %) minosha 282.00 (0.71 %) mkcl 345.00 (1.47 %) mobikwik 360.00 (2.86 %) mohan meakin 1,450.00 (3.57 %) mohfl 10.90 (-8.40 %) msei 0.91 (-1.09 %) msil 55.00 (1.85 %) nayara energy 200.00 (2.56 %) nayara energy ncd 255.00 (-1.92 %) ncdex 275.00 ncl buildtek 229.00 (0.88 %) ncl holdings 65.00 (3.17 %) nse 3,250.00 (1.56 %) orbis financial 90.00 (9.76 %) oswal minerals 63.00 (-3.08 %) otis 3,500.00 (-2.78 %) oyo 64.00 (-1.54 %) panasonic appliances 295.00 (0.68 %) panasonic avc 29.10 (0.34 %) paymate india 505.00 (-4.72 %) pharmeasy 20.80 (-0.95 %) philips 950.00 (-3.06 %) philips domestic 580.00 (1.75 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 320.00 (3.23 %) rasoi 31,500.00 (0.32 %) reliance gic 330.00 (-2.94 %) resins plastics 423.00 (0.71 %) ring plus 404.00 (-0.25 %) rrl 2,500.00 (-1.96 %) sab miller 305.00 (0.66 %) sbi amc 890.00 (-1.11 %) scottish assam 446.00 (0.68 %) shriram life 261.00 (0.38 %) sigachi lab 39.00 (-2.74 %) signify 1,400.00 (7.69 %) simpson & company 1,000,000.00 smile micro 52.00 (-1.89 %) sportskeeda 3,303.00 sterlite power 480.00 (1.05 %) studds 770.00 (-2.53 %) svsml 430.00 (-2.27 %) swiggy 361.00 (0.28 %) t stanes 750.00 (2.74 %) tata capital 178.00 (1.71 %) tata tech 875.00 (-0.57 %) teesta agro 85.00 (4.94 %) trl krosaki 1,255.00 (0.40 %) utkarsh core 135.00 (-1.46 %) vikram solar 350.00 (2.94 %) waree energie 600.00
×

Pharmeasy Share Price

Company Name
API Holdings Ltd
Last Traded Price (LTP)
20.80
% Change
-0.95 %
Scrip Name
PharmEasy
ISIN No.
INE0DJ201029
PAN No.
AASCA1201E
Face Value
1
No. of Outstanding Shares
6,142,041,070
Market Capitalization
12,775.45 Crore
Book value
11.433
P/BV
1.8193
EPS
-6.5
PE ratio
0
Available on
nsdlcdsl
ROFR Require
No

PharmEasy Share Price & Unlisted Shares - Company Overview   

API Holdings Limited formerly known as API Holdings Private Limited is an unlisted public limited company, incorporated on 31st March 2019.

API Holdings Limited is India's largest digital healthcare platform in terms of the gross merchandise value (GMV) of products and services sold.

The Company is engaged in diversified businesses primarily trading pharmaceutical and cosmetic goods, licensing of internet portals or mobile applications related to sales and distribution of pharmaceutical and cosmetic goods, diagnostic services, teleconsulting, etc.

API Holdings Ltd, the parent company of online pharmacy and health tech platform PharmEasy, which recently withdrew its IPO due to "market conditions and external factors”, recorded a larger loss for FY22 than the previous year. Pharmeasy share price has grown from a distributor of medicinal products to a fully integrated, digital healthcare platform that offers teleconsultation, medical equipment, and pharmaceuticals.

PharmEasy Share Price, Unlisted Share Details as of March 31, 2022

PharmEasy Outstanding Shares:

                                                                 5,530,566,129

Face Value of PharmEasy Unlisted Share:

Rs. 1 Per Equity Share

ISIN of PharmEasy Unlisted Share:

INE0DJ201029

Lot Size of PharmEasy Unlisted Share:

1000 Shares

PharmEasy Share Price:

Best in Industry

PAN Number of PharmEasy:

AASCA1201E

PharmEasy Incorporation Details

PharmEasy CIN Number

U60100MH2019PLC323444

PharmEasy Registration Date

31-Mar-19

Category / Sub-Category of PharmEasy

Limited by Shares/ Non-govt company

PharmEasy Registered Office Address

Unit No 104, Marwahs Complex 4, Marwah Estate, Krishnalal, Marwah Marg, Mumbai - 400072

PharmEasy Registrar & Transfer Agent Address and Contact Details

Link InTime India Private Limited, 902, 9TH Floor, Raheja Plaza 1, B Wing, Opposite R City Mall, L.B.S Marg, Ghatkopar, Mumbai - 400086

PharmEasy Board of Directors

Mr. Aditya Puri, Chairman, Non-Executive Director

Mr. Deepak Vaidya, Independent, Non-Executive Director

Mr. Ankur Thadani, Non-Executive Director

Mr. Ashutosh Sharma, Non-Executive Director

Ms. Vineeta Rai, Independent, Non-Executive Director

Dr. Jaydeep Tank, Independent, Non-Executive Director

Mr. Subramaniam Somasundaram, Independent, Non-Executive Director

Mr. Siddharth Shah, MD, and CEO

Mr. Harsh Parekh, Whole-time Director

Mr. Dharmil Sheth, Whole-time Director

PharmEasy Subsidiary & Associate Companies 

S. No. Name of the Company Holding/ Subsidiary/ Associate % of Shares held

1.

Threpsi Solutions Private Limited

Subsidiary

100

2.

ARZT and Health Private Limited

Subsidiary

100

3.

Ascent Wellness and Pharma Solutions Private Limited

Subsidiary

100

4.

Docon Technologies Private Limited

Subsidiary

100

5.

Thyrocare Technologies Limited

Subsidiary

71.18

6.

AKP Healthcare Private Limited

Subsidiary

51

7.

Ayro Retail Solutions Private Limited

Subsidiary

100

8.

Venkatesh Medico Private Limited

Subsidiary

51

9.

Instinct Innovation s Private Limited

Subsidiary

100

10.

Eastern Agencies Healthcare Private Limited

Subsidiary

100

11.

MARG ERP Ltd

Associate

99.23

12.

Equinox Labs Limited

Associate

209.2

13.

Impex Healthcare Private Limited

Associate

90.30

PharmEasy Industry Outlook

According to a Red Seer Report, the company has a target addressable market of Rs. 10.4 trillion ($139 billion) as of 2020, which corresponds to the size of the entire Indian Healthcare market in 2020. The target addressable market is expected to grow at a 14% CAGR to reach $20 trillion ($266 billion) by 2025.

Online pharmacy-led play: Online pharmacies, consisting of at-home delivery of prescription medicines, covered 63% of the market pre-COVID in 2019 and held 55% of the market in 2020, despite the disruption in pharma supply. eOTC is the second-largest segment, constituting doorstep delivery of generic medicines and health products. It accounted for 26% of the market share before COVID, which soared to 35% in 2020, owing to the high demand for COVID-related OTC products.

Large headroom ahead: Despite the high growth, digital penetration in health (across pharma, OTC, diagnostics, and consultation) is only at 2%, indicating a very nascent stage of penetration. For example, online pharmacy penetration in India was 2.3% in 2020, significantly lower than in China (10-15%) and the United States (30-35%). 

FAQs on PharmEasy

Q.1 Does PharmEasy have an IPO?

A.1 PharmEasy is preparing to launch its IPO.

Q.2 How do I buy PharmEasy shares?

A.2 One can buy PharmEasy shares online through our website, or investors can call us and confirm the deal with our Relationship Manager at 966999944, 7999252591, or 0731-4025544.

Q.3 Is PharmEasy a profitable company?

A.3 No, the company has not yet been profitable because PharmEasy suffered a loss of 39,924.96 million in FY 2022.

Q.4 What is Phrameasy share price today?

A.4  Pharmeasy share price used to change every day like other companies ' share prices. To find out the most recent Phrameasy share price contact us

Recent News

Wealth Wisdom - WWIPL
Support Megha Support Neha